Sofinnova Investments, Inc. Biocryst Pharmaceuticals Inc Transaction History

Sofinnova Investments, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.56 - $19.76 $17.5 Million - $29.8 Million	-1,510,473 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.18 - $15.46 $16.9 Million - $23.4 Million	1,510,473 New	1,510,473 $20.9 Million
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $2.25 Million - $2.8 Million	-158,609 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$9.5 - $17.24 $2.09 Million - $3.8 Million	-220,165 Reduced 58.13%	158,609 $2.51 Million
Q1 2021 May 14, 2021	SELL	$7.37 - $13.61 $5.48 Million - $10.1 Million	-744,026 Reduced 66.27%	378,774 $3.85 Million
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $1.11 Million - $2.84 Million	329,746 Added 41.58%	1,122,800 $8.37 Million
Q3 2020 Nov 13, 2020	SELL	$3.43 - $5.53 $1.94 Million - $3.12 Million	-564,794 Reduced 41.59%	793,054 $2.73 Million
Q2 2020 Aug 13, 2020	BUY	$1.9 - $5.61 $1.03 Million - $3.04 Million	542,158 Added 66.47%	1,357,848 $6.47 Million
Q1 2020 May 13, 2020	SELL	$1.6 - $4.11 $2.14 Million - $5.49 Million	-1,335,474 Reduced 62.08%	815,690 $1.63 Million
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $2.6 Million - $5.64 Million	1,634,430 Added 316.3%	2,151,164 $7.42 Million
Q3 2019 Nov 14, 2019	BUY	$2.5 - $3.73 $225,835 - $336,945	90,334 Added 21.19%	516,734 $1.48 Million
Q2 2019 Aug 13, 2019	BUY	$2.91 - $9.15 $1.24 Million - $3.9 Million	426,400 New	426,400 $1.62 Million

280

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.